The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.00
Bid: 42.50
Ask: 43.50
Change: 0.10 (0.23%)
Spread: 1.00 (2.353%)
Open: 43.00
High: 44.10
Low: 42.50
Prev. Close: 44.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Mon, 11th May 2020 12:03

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Open Orphan PLC - pharmaceutical services - Subsidiary hVIVO enters contract with Nasdaq-listed diagnostics firm Quotient to use MosaiQ system and MosaiQ Covid-19 antibody microarray to screen for SARS-CoV-2 antibodies, which is produced when humans are infected with Covid-19.

----------

Avacta Group PLC - biotherapeutics - To ship Affimer reagents for the development of a point-of-care saliva-based Covid-19 antigen test strip by Cytiva, for CE Marking in Europe and US Food & Drug Administration approval. Will also be sent to Adeptrix, which is developing Covid-19 laboratory test to run on hospital mass spectrometers.

----------

BlueRock Diamonds PLC - diamonds - Recommences operations at Kareevlei diamond mine in Kimberley, South Africa. Expects to start operations at full capacity by the end of May, but expansion plans on hold.

----------

Chesterfield Resources PLC - mineral exploration - Plans to resume drilling operations on its Troodos West licences by mid-June, following government of Cyprus providing a detailed four-phase roadmap out of lockdown, which is spread over the next two months up until July 14.

----------

Blencowe Resources PLC - mining - Recommences key metallurgical test work on Orom-Cross graphite project in Uganda, after being on hold for six weeks since late March due to lockdown. Due to restart 59-hole diamond drilling programme, which is designed to deliver a maiden JORC resource during the middle of 2020.

----------

Phoenix Spree Deutschland Ltd - real estate - Rent collection for April at 98% compared to 99% in January. Refinances EUR16.4 million in debt acquired as part of acquisition of Brandenburg apartment complex. Will pay second dividend of 5.15 cents per share, remain confident in long-term outlook.

----------

Petro Matad Ltd - Mongolian oil explorer - Executive directors, non-executive directors and senior managers to take salary cut averaging 50%, backdated to the start of second quarter of 2020. Professional advisers to reduce its fees by up to 45%. To focus on securing Block XX exploitation licence and retaining its Block V exploitation licence.

----------

Anglo African Agriculture PLC - agriculture investment - Trading subsidiary Dynamic Intertrade remains fully operational despite South Africa lockdown, due to providing essential services as a food manufacturer. Expects revenue for six months ending October 31 to double year-on-year. Progress with Comarco transaction protracted due to general market environment.

----------

iEnergizer Ltd - media and technology services - Continues to trade effectively in lockdown imposed by government of India. Business operating at 80% to 90% efficiency to its clients. Balance sheet, net cash position and long-term customer relationships remain strong.

----------

Cake Box Holdings PLC - cakes retailer - Following initial trial of limited number of stores operating Click & Collect service and delivery in partnership, now has 79 franchise stores open, offering a limited menu of products. Expects to have full high street estate open by early June.

----------

Midwich Group PLC - audio-visual distributor - Delivered strong performance in 2019, with growth in revenue and rise in profit. Challenging trading conditions over the past two months, expected to continue until lockdown conditions in Europe and North America are "significantly eased".

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Aug 2021 11:29

Avacta doses first patient in chemotherapy medication trial

Avacta doses first patient in chemotherapy medication trial

Read more
11 Aug 2021 10:00

First patient dosed in Avacta's 'AVA6000' trial

(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that the first patient has been dosed in its phase 1 multicentre trial evaluating 'AVA6000', which it described as a "novel pro-drug" of 'doxorubicin', and its first therapeutic product based on the proprietary 'preCISION' technology.

Read more
4 Aug 2021 17:53

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

Read more
14 Jul 2021 11:30

AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down

AIM WINNERS & LOSERS: Tern raises GBP6 million; Kromek revenue down

Read more
14 Jul 2021 11:10

IN BRIEF: Avacta wins manufacturer certification for lateral flow test

IN BRIEF: Avacta wins manufacturer certification for lateral flow test

Read more
14 Jul 2021 09:02

Avacta gets ISO certification for Affirmer manufacture and distribution

(Sharecast News) - Diagnostics and cancer therapies developer Avacta announced on Wednesday that its life sciences diagnostics division has achieved ISO 13485 certification on the quality management system for the manufacture and distribution of 'Affimer' reagents, for use in lateral flow, ELISA and immunodiagnostic in-vitro diagnostic devices.

Read more
29 Jun 2021 12:12

IN BRIEF: Avacta's lateral flow test detects Covid Delta variant

IN BRIEF: Avacta's lateral flow test detects Covid Delta variant

Read more
29 Jun 2021 11:37

AIM WINNERS & LOSERS: Avacta virus test works; React virus boost ebbs

AIM WINNERS & LOSERS: Avacta virus test works; React virus boost ebbs

Read more
29 Jun 2021 08:36

Avacta rapid Covid-19 test detects Delta variant in study

(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group announced on Tuesday that a study has shown that its 'AffiDX' antigen lateral flow test detects the 'Delta' variant of the SARS-CoV-2 virus in clinical samples.

Read more
23 Jun 2021 10:28

AIM WINNERS & LOSERS: Mercantile Ports jumps on pact; Avacta recovers

AIM WINNERS & LOSERS: Mercantile Ports jumps on pact; Avacta recovers

Read more
21 Jun 2021 19:24

IN BRIEF: Avacta signs distribution deal for its Covid test

IN BRIEF: Avacta signs distribution deal for its Covid test

Read more
21 Jun 2021 16:11

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
21 Jun 2021 08:37

Avacta enters non-exclusive distribution deal for Covid-19 test

(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group has entered into a non-exclusive distribution agreement with life science products company Calibre Scientific, it announced on Monday, for its 'AffiDX' SARS-CoV-2 antigen lateral flow test for professional use in the UK and the European Economic Area (EEA).

Read more
11 Jun 2021 12:27

Avacta to sell rapid Covid-19 test in EU following registration

(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group has received notice of registration of its 'AffiDX' SARS-CoV-2 antigen lateral flow test in the European Union, allowing it to place the product on the market for professional use in all 27 countries of the EU.

Read more
11 Jun 2021 11:40

Avacta Covid lateral flow test gets regulatory green light in EU

Avacta Covid lateral flow test gets regulatory green light in EU

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.